Federal contractor · MENLO PARK, CA

VCREATE, INC

No contract obligations recorded for VCREATE, INC in FY2026. Since FY2024: $355K. It also received $200K in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
TDGANH2K4J93
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 355KFY2024
  2. 0FY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for VCREATE, INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

VCREATE, INC received $200K in federal assistance in FY2026, on 1 actions (0 new awards), +2,400% vs FY2025. Its largest program was 47.084 · Technology, Innovation, and Partnerships ($200K).

Assistance · FY2026
$200K
New awards
0
Actions
1
Since FY2022
$1.7M

Assistance by fiscal year

  1. 512.6KFY2022
  2. 0FY2023
  3. 1MFY2024
  4. 8KFY2025
  5. 200KFY2026

By type

  1. Grants$200K100%

Top programs

  1. 47.084 · Technology, Innovation, and Partnerships$200K100%

Awarding agencies

  1. National Science Foundation$200K100%

Largest awards

  1. SBIR PHASE II: HIGH THROUGHPUT AND ANTIGEN SPECIFIC T-CELL RECEPTOR DISCOVERY FOR SOLID TUMOR TREATMENTS -THE BROADER IMPACT OF THIS SMALL…$1.2M
    47.084 · Technology, Innovation, and Partnerships· National Science Foundation· Cooperative agreement· Aug 7, 2024 – Mar 12, 2026· 2406662

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2022–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. ATUX ISKAY GROUP LLC$355K
    PLAINSBORO, NJ · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. TRANQUILITY BIODESIGN LLC$355K
    COLLEGE STATION, TX · 100.0% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. QANA THERAPEUTICS INC.$354.7K
    AUSTIN, TX · 99.9% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.